Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AQST · as of Sep 30, 2025
Ownership Breakdown
158
Institutional Holders
▲ 39 vs Q2
$369.39M
Total Inst. Value
▲ $211.80M vs Q2
99.31M
Shares Outstanding
freeFloat 96.04%
66.07M
13F Shares Held
▲ 18.47M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AQST largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BRATTON CAPITAL MANAGEMENT, L.P. pharmaceutical preparations | 9.81M | 9.88% | 9.88% | $54.84B | Nov 14, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 6.53M | 6.57% | 6.57% | $36.48B | Nov 12, 2025 | ▲ 49.1K |
RTW INVESTMENTS, LP pharmaceutical preparations | 6.25M | 6.29% | 6.29% | $34.94B | Nov 14, 2025 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 5.66M | 5.70% | 5.70% | $31.65B | Nov 7, 2025 | ▲ 1.33M |
PERCEPTIVE ADVISORS LLC pharmaceutical preparations | 3.76M | 3.79% | 3.79% | $21.02B | Nov 14, 2025 | ▲ 1.57M |
ECOR1 CAPITAL, LLC pharmaceutical preparations | 2.63M | 2.64% | 2.64% | $14.67B | Nov 14, 2025 | NEW |
SAMSARA BIOCAPITAL, LLC pharmaceutical preparations | 2.50M | 2.52% | 2.52% | $13.97B | Nov 14, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 2.09M | 2.10% | 2.10% | $11.67B | Nov 12, 2025 | ▲ 110.9K |
STATE STREET CORP pharmaceutical preparations | 1.60M | 1.61% | 1.61% | $8.96B | Nov 14, 2025 | ▲ 94.9K |
SIO CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.50M | 1.51% | 1.51% | $8.37B | Nov 13, 2025 | ▲ 550.6K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
29
Increased
+7.98M shares11
New Positions
first time holders7
Decreased
−2.21M shares0
Sold Out
fully exitedNet shares change (top 50)
+5.77M
+7.98M / −2.21M
Net new holders
+33
11 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AQST insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
8
Sell transactions
0.25
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Zalewski Thomas A. Chief Legal Officer | May 18, 2026 | Award | 100,000 | — | — | 100.0K | Form 4 ↗ |
Zalewski Thomas A. Chief Legal Officer | May 18, 2026 | Award | 75,000 | $4.13 | $310.1K | 75.0K | Form 4 ↗ |
Barber Daniel President and CEO | May 15, 2026 | Sale | 8,257 | $4.29 | $35.4K | 660.6K | Form 4 ↗ |
Cioffi Melina SVP, Regulatory Affairs | May 15, 2026 | Tax Withhold | 1,667 | $4.17 | $7.0K | 273.2K | Form 4 ↗ |
BRAENDER LORI J Corporate Secretary | May 7, 2026 | Tax Withhold | 135,690 | $4.23 | $574.0K | 231.0K | Form 4 ↗ |
Boyd Peter E. Chief People Officer | May 5, 2026 | Tax Withhold | 56,778 | $4.18 | $237.3K | 281.7K | Form 4 ↗ |
Barber Daniel President and CEO | May 5, 2026 | Tax Withhold | 335,922 | $4.18 | $1.40M | 668.8K | Form 4 ↗ |
TOTH A ERNEST JR Chief Financial Officer | May 5, 2026 | Tax Withhold | 92,652 | $4.18 | $387.3K | 283.5K | Form 4 ↗ |
Jung Cassie Chief Operating Officer | May 5, 2026 | Tax Withhold | 72,734 | $4.18 | $304.0K | 202.2K | Form 4 ↗ |
BRAENDER LORI J Corporate Secretary | May 5, 2026 | Tax Withhold | 76,147 | $4.18 | $318.3K | 366.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Aquestive Therapeutics, Inc. (AQST) is primarily owned by institutional investors, who hold approximately 66.5% of total shares outstanding. Company insiders own approximately 3.96%, while retail and public investors account for the remaining 29.51%.
The largest institutional shareholder of Aquestive Therapeutics, Inc. is BRATTON CAPITAL MANAGEMENT, L.P., holding approximately 9.81 million shares — equal to 9.88% of outstanding shares — as of September 30, 2025.
A total of 158 institutional investors currently hold AQST stock, with a combined institutional value of approximately $369,388,794 as of the most recent 13F filing period.
Frequently asked questions
AQST ownershipAquestive Therapeutics, Inc. (AQST) is primarily owned by institutional investors, who hold approximately 66.5% of shares. The largest shareholder is BRATTON CAPITAL MANAGEMENT, L.P. with a 9.88% stake. Company insiders hold 3.96%. Data sourced from SEC Form 13F as of September 30, 2025.